Brand Name | Status | Last Update |
---|---|---|
albumin (human) | Biologic Licensing Application | 2010-01-07 |
albumin (human) 20% | Biologic Licensing Application | 2009-12-16 |
albumin (human) 25% | Biologic Licensing Application | 2009-12-22 |
albuminex | Biologic Licensing Application | 2024-12-31 |
alburx | Biologic Licensing Application | 2009-01-06 |
albutein | Biologic Licensing Application | 2008-07-01 |
beizray | New Drug Application | 2024-11-04 |
definity | New Drug Application | 2024-03-13 |
definity rt | New Drug Application | 2024-03-13 |
draximage maa | Biologic Licensing Application | 2024-02-13 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | — | — | 1 | 2 | 3 |
Echocardiography | D004452 | — | — | — | — | — | 2 | — | 2 |
Congenital abnormalities | D000013 | EFO_0003915 | Q89.9 | — | — | — | 1 | — | 1 |
Systolic murmurs | D054160 | — | R01.1 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Coronary disease | D003327 | — | — | — | — | 1 | — | — | 1 |
Coronary artery disease | D003324 | — | I25.1 | — | — | 1 | — | — | 1 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 1 | — | — | 1 |
Myocardial perfusion imaging | D055414 | — | — | — | — | 1 | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | — | — | 1 | — | — | 1 |
Hepatocellular carcinoma | D006528 | — | C22.0 | — | — | 1 | — | — | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | 1 | — | — | 1 |
Therapeutic chemoembolization | D016461 | — | — | — | — | 1 | — | — | 1 |
Prostatic neoplasms | D011471 | — | C61 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carotid artery diseases | D002340 | EFO_0003781 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 1 | 1 |
Tricuspid valve insufficiency | D014262 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Albumin human |
INN | perflutren |
Description | Octafluoropropane is a fluorocarbon that is propane in which all of the hydrogens have been replaced by fluorines. It is a fluorocarbon and a fluoroalkane. It derives from a hydride of a propane. |
Classification | Protein |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201451 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | CK0N3WH0SR (ChemIDplus, GSRS) |